Bernard Lelong

About

Bernard Lelong is a leading French colorectal surgeon whose research focuses on optimizing surgical outcomes for rectal and colon cancer, particularly through minimally invasive techniques and enhanced recovery protocols. His most impactful work, the GRECCAR 2 randomized phase 3 trial (2014), compared local excision versus total mesorectal excision in T2-T3 low rectal cancer patients with good response to neoadjuvant radiochemotherapy, providing pivotal evidence for organ-preserving strategies. This study, with 14 citations, has influenced clinical decision-making in sphincter-sparing surgery. More recently, Lelong has advanced the field of Enhanced Recovery After Surgery (ERAS), demonstrating in a 2024 study (7 citations) how ERAS programs improve the diagnosis and management of postoperative complications after laparoscopic or robotic colectomy for cancer. He also contributed to official expert recommendations (2022) for robotic-assisted right colectomy under the French Association of Surgery, establishing best practices for this emerging technique. Through these contributions, Lelong has shaped modern colorectal surgery by integrating oncologic precision with patient-centered recovery, making him a key figure in the evolution of minimally invasive and enhanced recovery paradigms.

Research Focus

Key Achievements

Top Papers

1. 1
   Local Excision Versus Total Mesorectal Excision in Patients with Good Response After Neoadjuvant Radiochemotherapy for T2-T3 Low Rectal Cancer: Preliminary Results of the GRECCAR 2 Randomized Phase 3 Trial

   14 citations · 2014
2. 2
   Impact of an Enhanced Recovery After Surgery (ERAS) program on the management of complications after laparoscopic or robotic colectomy for cancer

   7 citations · 2024
3. 3
   Robotic-assisted right colectomy. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC)

   4 citations · 2022

Key Collaborators

Contact & Links